Institute of Biomedical Research Corp. (MRES)
| Market Cap | 44.38M |
| Revenue | n/a |
| Net Income | n/a |
| Shares Out | 2.40B |
| EPS | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 120,000 |
| Average Volume | 806,026 |
| Open | 0.0185 |
| Previous Close | 0.0185 |
| Day's Range | 0.0166 - 0.0185 |
| 52-Week Range | 0.0001 - 0.0280 |
| Beta | 2.47 |
| RSI | 52.43 |
| Earnings Date | n/a |
About MRES
Institute of Biomedical Research Corp. provides biomedical research and analytical services in Montenegro and internationally. Its services include regulatory control of industrial activities and products; scientific surveillance of the living environment; research and development of biomedical products and technologies; regulatory evaluation and certification of biomedical products; fundamental scientific research; and development of new diagnostic methods and experimental medical treatments. The company also researchers and develops new biome... [Read more]
News
RLAB & MRES: Tiago Henriques Joins M2MMA Combat Sports Promotion Advisory Board
DUBAI, UAE / ACCESS Newswire / January 24, 2025 / Real American Capital Corp (OTC PINK:RLAB), trading as M2MMA, is an avant-garde powerhouse reshaping the combat sports landscape. It is thrilled to an...
MRES: Dr. Esmarilda Dankaert Appointed Chief Innovation Officer (CINO) at M2Bio Sciences
DUBAI, UAE / ACCESSWIRE / November 25, 2024 / The Institute of Biomedical Research Corp. (OTC PINK:MRES), operating as M2Bio Sciences, is a pioneering biotechnology company dedicated to advancing heal...
MRES: M2Bio Food and Beverage Refocuses Strategy: Expanding Beyond CBD to Reach Global Consumers
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / August 22, 2024 / The Institute of Biomedical Research Corp. (OTC PINK:MRES), a pioneering nutraceutical biotechnology company that delves into the innovative re...
RLAB: M2MMA Welcomes Legendary Muay Thai Icon Sagat Petchyindee to Advisory Board!
DUBAI, UNITED ARAB EMIRATES / ACCESSWIRE / May 16, 2024 / Real American Capital Corp (OTC PINK:RLAB), trading as M2MMA, a leader in mixed martial arts, is thrilled to announce the appointment of Sagat...
MRES: M2Bio Food and Beverage Wraps Up 2023/ 2024 Looking Ahead
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / March 22, 2024 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specialising in alter...
MRES: M2Bio Sciences Provides Corporate Update
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / March 1, 2024 / Institute of Biomedical Research Corporation (OTC PINK:MRES) is pleased to provide further details of the sale to Real American Capital Corporati...
MRES: M2Bio Sciences Introduces M2BioKids: A Pioneering Approach to Elevating Childhood Health and Development
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / February 23, 2024 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in al...
MRES: M2Enviro 2023 Year-End Review and 2024 Looking Forward
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / February 22, 2024 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology,specializing in alt...
MRES: M2Biome 2023 Year-End Review and 2024 Looking Forward
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / February 9, 2024 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in alt...
Real American Announces Acquisition of M2MMA from MRES
PALM SPRINGS, CA / ACCESSWIRE / January 30, 2024 / The Real American Capital Corporation (OTC PINK:RLAB) is pleased to announce the acquisition from Institute of Biomedical Research Corporation (OTC P...
Real American Announces Appointment of Officers and Directors
PALM SPRINGS, CA / ACCESSWIRE / January 18, 2024 / The Real American Capital Corporation (OTC PINK:RLAB) announced today the appointment of Jeff Robinson as Chairman and Director and Willem Jonker as ...
MRES: M2MMA Gears Up for a Landmark Year in 2024
CAPE TOWN / ACCESSWIRE / January 2, 2024 / CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / January 2, 2024 / Institute of Biomedical Research Corp. (OTC PINK: MRES), a vanguard entity at the forefront of nutra...
MRES: M2Bio Sciences Expands Global Presence with New Offices in Dubai Science Park
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / November 15, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES): A pioneering force in nutraceutical biotechnology, specializing in alternative plant-...
MRES: M2Bio Sciences Marks Milestone Expansion with Launch of Los Angeles Office
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / November 14, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology specializing in alt...
African Ginger Patented for Influenza and SARS-CoV-2 Treatment: Insights from M2Bio Sciences Research Chair
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / November 3, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology specializing in alte...
M2MMA Announces 2024 Fight Schedule and Appoints CEO
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / October 12, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in alt...
M2Bio Sciences Chair, Prof Maharaj, to Deliver Keynote Address on Cutting-Edge Biotechnology Advancements
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / October 2, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in alte...
M2Bio Sciences Closes JDAX Acquisition
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / September 21, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in a...
M2Bio Sciences Pharmacology & Clinical Application of CBD
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / September 15, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in a...
M2Bio-Discovery Centre for AI-Driven Phytomedicine Research: Update
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / September 13, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in a...
M2bio Sciences Announces Launch of Exclusive MMA Organization
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / August 17, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES) ("Institute of Biomedical Research" or the "Company"), a pioneering force in nutraceutic...
MRES: M2Bio Sciences Appoints Adrian J. Maizey, Accomplished CEO and Financial Expert, to Advisory Board
CAPE TOWN, South Africa, July 19, 2023 (GLOBE NEWSWIRE) -- via IBN -- Institute of Biomedical Research Corp. (OTC PINK: MRES) ("Institute of Biomedical Research" or the "Company"), a nutraceutical bio...
MRES: M2Bio Sciences Unveils an Exciting Line of Purple, White, and Green Teas from Kenya, Exhibiting Numerous Medicinal Health Benefits
CAPE TOWN, South Africa, July 17, 2023 (GLOBE NEWSWIRE) -- via IBN -- Institute of Biomedical Research Corp. (OTC PINK: MRES) (“Institute of Biomedical Research” or the "Company"), a nutraceutical bio...
MRES: Institute of Biomedical Research Announces Application for Name Change and New Ticker Symbol in Anticipation of Future M&A Activities and Senior Listing
MRES: Institute of Biomedical Research Announces Application for Name Change and New Ticker Symbol in Anticipation of Future M&A Activities and Senior Listing CAPE TOWN, South Africa , July 5, 2023 /...
MRES: M2Bio Sciences Enters into Letter of Intent to Acquire Crypto Exchange JDAX
CAPE TOWN, South Africa , June 27, 2023 /PRNewswire/ -- Institute of Biomedical Research Corp. (OTC PINK: MRES) ("Institute of Biomedical Research" or the "Company"), a nutraceutical biotechnology com...